WHO Raises Alarm Over Fake Ozempic Drugs: Health Risks and Safety Alerts

The World Health Organization (WHO) issued a global alert addressing the distribution of counterfeit Ozempic, a diabetes drug also used for weight loss. The WHO underscores the serious health risks of these fake drugs, which may lack the active ingredient semaglutide or contain harmful substances. The alert follows an increase in reports of falsified Ozempic and advises sourcing from reputable providers only.